Monoclonal Antibodies Market Size, Share, Opportunities, COVID 19 Impact, And Trends By Indication (Inflammatory Disease, Cancer, Microbial Disease, Others), By Source (Humanized, Human, Chimeric, Murine), By Application (Diagnostic, Therapeutic, Others), By End-User (Hospitals & Clinics, Research Laboratories), And By Geography - Forecasts From 2020 To 2025

Published:  Jun 2021 Report Code: KSI061610595 Pages: 124

The monoclonal antibodies market is projected to grow at a CAGR of 5.77% to reach US$158.598 billion by 2025, from US$106.134 billion in 2019. Monoclonal is a class of antibodies with identical offspring of a hybridoma, derived by cell division from a single ancestral cell. The market for monoclonal antibodies is driven by persistent innovation in drug development and discovery, increasing incidences of chronic diseases, favorable regulatory policies, and high adoption rate of therapeutic antibodies in emerging economies.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the monoclonal antibodies value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the monoclonal antibodies market.

Major industry players profiled as part of the report are Merck & Co. Inc., Novartis AG, Abbot, and Johnson & Johnson Services, Inc. among others.

Monoclonal Antibodies Market Scope:

Report Metric Details
 Market size value in 2019  US$106.134 billion
 Market size value in 2025  US$158.598 billion
 Growth Rate  CAGR of 5.77% from 2019 to 2025
 Base year  2019
 Forecast period  2020–2025
 Forecast Unit (Value)  USD Billion
 Segments covered  Indication, Source, Application, End-User, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered  Eli Lily and Company, AbbVie, Inc., Novartis AG, Bristol Myers Squibb, F.Hoffmann-La   Roche Ltd, Johnson & Johnson Services, Inc., Amgen Inc., Merck & Co. Inc., Abbot,   AstraZeneca PLC
 Customization scope  Free report customization with purchase

Segmentation

The monoclonal antibodies market has been analyzed through the following segments:

By Indication

Inflammatory Disease

Cancer

Microbial Disease

Others

 

By Source

Humanized

Human

Chimeric

Murine

 

By Application

Diagnostic

Therapeutic

Others

 

By End-User

Hospitals & Clinics

Research Laboratories

 

 

By Geography

North America

USA

Canada

Mexico

Others

 

South America

Brazil

Argentina

Others

 

Europe

Germany

France

United Kingdom

Others

 

Middle East and Africa

Saudi Arabia

Israel

Others

 

Asia Pacific

China

Japan

South Korea

India

Others


Frequently Asked Questions (FAQs)

Q1. What will be the monoclonal antibodies market size by 2025?
A1. The monoclonal antibodies market is projected to reach a market size of US$158.598 billion by 2025.

Q2. What is the size of monoclonal antibodies market?
A2. Monoclonal Antibodies market was valued at US$106.134 billion in 2019.

Q3. What are the growth prospects for monoclonal antibodies market?
A3. The monoclonal antibodies market is projected to grow at a CAGR of 5.77% over the forecast period.

Q4. Who are the major players in the monoclonal antibodies market report?
A4. Major industry players profiled as part of the report are Merck & Co. Inc., Novartis AG, Abbot, and Johnson & Johnson Services, Inc. among others.

Q5. How is the monoclonal antibodies market segmented?
A5. The monoclonal antibodies market has been segmented by indication, source, application, end-user, and geography.

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY  
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Product Pipeline
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. MONOCLONAL ANTIBODIES MARKET BY INDICATION
5.1. Inflammatory Disease
5.2. Cancer
5.3. Microbial Disease
5.4. Others
6. MONOCLONAL ANTIBODIES MARKET BY SOURCE
6.1. Humanized
6.2. Human
6.3. Chimeric
6.4. Murine
7. MONOCLONAL ANTIBODIES MARKET BY APPLICATION
7.1. Diagnostic
7.2. Therapeutic 
7.3. Others
8. MONOCLONAL ANTIBODIES MARKET BY END-USER
8.1. Hospitals & Clinics
8.2. Research Laboratories
9. MONOCLONAL ANTIBODIES MARKET BY GEOGRAPHY
9.1. North America
9.1.1. USA
9.1.2. Canada
9.1.3. Mexico
9.1.4. Others
9.2. South America
9.2.1. Brazil
9.2.2. Argentia
9.2.3. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Others
9.4. Middle East and Africa
9.4.1. Saudi Arabia
9.4.2. Israel
9.4.3. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. South Korea
9.5.4. India
9.5.5. Others
10. COMPETITIVE INTELLIGENCE
10.1.  Market Share of Key Players
10.2.  Recent Investment and Deals
10.3. Strategies of Key Players
11. COMPANY PROFILES
11.1. Eli Lilly and Company
11.1.1. Company Overview
11.1.2. Financials
11.1.3. Products and Services
11.1.4. Recent Developments
11.2. AbbVie, Inc.
11.2.1. Company Overview
11.2.2. Financials
11.2.3. Products and Services
11.2.4. Recent Developments
11.3. Novartis AG
11.3.1. Company Overview
11.3.2. Financials
11.3.3. Products and Services
11.3.4. Recent Developments
11.4.  Bristol Myers Squibb
11.4.1. Company Overview
11.4.2. Financials
11.4.3. Products and Services
11.4.4. Recent Developments
11.5.  F. Hoffmann-La Roche Ltd
11.5.1. Company Overview
11.5.2. Financials
11.5.3. Products and Services
11.5.4. Recent Developments
11.6. Johnson & Johnson Services, Inc.
11.6.1. Company Overview
11.6.2. Financials
11.6.3. Products and Services
11.6.4. Recent Developments
11.7. Amgen Inc.
11.7.1. Company Overview
11.7.2. Financials
11.7.3. Products and Services
11.7.4. Recent Developments
11.8. Merck & Co. Inc. 
11.8.1. Company Overview
11.8.2. Financials
11.8.3. Products and Services
11.8.4. Recent Developments
11.9. Abbot
11.9.1. Company Overview
11.9.2. Financials
11.9.3. Products and Services
11.9.4. Recent Developments
11.10. AstraZeneca PLC
11.10.1. Company Overview
11.10.2. Financials
11.10.3. Products and Services
11.10.4. Recent Developments
LIST OF FIGURES
LIST OF TABLES
 
Eli Lily and Company
AbbVie, Inc.
Novartis AG
Bristol Myers Squibb
F.Hoffmann-La Roche Ltd
Johnson & Johnson Services, Inc.
Amgen Inc.
Merck & Co. Inc.
Abbot
AstraZeneca PLC
 

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us